Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

101.81
+0.74000.73%
Volume:81.58K
Turnover:8.34M
Market Cap:1.63B
PE:9.48
High:103.00
Open:102.65
Low:101.78
Close:101.07
52wk High:108.66
52wk Low:69.02
Shares:16.00M
Float Shares:16.00M
Volume Ratio:0.60
T/O Rate:0.51%
Dividend:1.47
Dividend Rate:1.44%
EPS(TTM):10.74
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Berenberg Upgrades Eli Lilly and Co. to Buy From Hold, Adjusts Price Target to $1,400 From $1,220

MT Newswires Live
·
1 hour ago

Lilly Gains After Berenberg Upgrades to 'buy' on Obesity Pill Momentum

Reuters
·
2 hours ago

U.S. Research Roundup- Eli Lilly, McDonald's, Welltower

Reuters
·
3 hours ago

Eli Lilly : Berenberg Raises to Buy from Hold; Raises Target Price to $1,400 from $1,220

THOMSON REUTERS
·
5 hours ago

JNJ Reports Low Rates of Treatment-Related Events for Rybrevant Faspro Plus Lazcluze at Wclc 2026

Reuters
·
7 hours ago

J&J - Fewer than 1% Discontinue Rybrevant Faspro Plus Lazcluze Due to Treatment-Related Events at One Year

THOMSON REUTERS
·
7 hours ago

RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)

TIPRANKS
·
9 hours ago

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
9 hours ago

Contineum Therapeutics Says Phase 2 Major Depressive Disorder Study Fails to Meet Primary Efficacy Endpoint

MT Newswires Live
·
13 hours ago

Medtronic PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
14 hours ago

Contineum Therapeutics Shares Fall After Drug Trial Missed Primary Endpoint

Dow Jones
·
14 hours ago

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
14 hours ago

Contineum, J&J's Depression Drug Fails to Meet Mid-Stage Trial Goal

Reuters
·
14 hours ago

Contineum Therapeutics, - Johnson & Johnson Continues to Evaluate Trial Data for Jnj-5120/Pipe-307

THOMSON REUTERS
·
14 hours ago

Merck & Co Exec Says Potential 340B and Policy Evolutions Would Create Tailwinds but are not Material to the Business - Morgan Stanley Conf

THOMSON REUTERS
·
15 hours ago

Merck & Co Exec Says Timing for Raising the $70 Bln Forecast is "to be Determined" Adds "It's Coming"

THOMSON REUTERS
·
15 hours ago

Eli Lilly Stock (LLY) Has 45% Upside, Says Citigroup

TIPRANKS
·
15 hours ago

Novo Nordisk is Dropping Some Weight. it Still Faces a Bigger Challenge.

Dow Jones
·
16 hours ago

Eli Lilly Exec Says Co NOW Has More than 30% Share in New Starts Within Oral Obesity Treatment Market -Morgan Stanley Conf

THOMSON REUTERS
·
16 hours ago

Eli Lilly and Co Stock (LLY) Moved Up by 3.01% on Sep 14: Drivers Behind the Movement

TradingKey
·
18 hours ago